Cargando…

Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study

PURPOSE: Selective serotonin reuptake inhibitors (SSRIs) enhance angiogenesis and neurogenesis. Brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) play an important role in neurogenesis and angiogenesis. However, the effect of SSRIs on cognition and serum BDNF and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Liu, Xuan, Li, Tong, Xu, Bing, Fu, Binfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721155/ https://www.ncbi.nlm.nih.gov/pubmed/35002241 http://dx.doi.org/10.2147/NDT.S334647

Ejemplares similares

Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter]
por: Brück, Chiara C
Publicado: (2022)

Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia
por: Liu, Xuan, et al.
Publicado: (2014)

Increased BDNF may not be associated with cognitive impairment in heroin-dependent patients
por: Luan, Xiaoqian, et al.
Publicado: (2017)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Stroke injury, cognitive impairment and vascular dementia()
por: Kalaria, Raj N., et al.
Publicado: (2016)

Potential Therapeutics for Vascular Cognitive Impairment and Dementia
por: Sun, Miao-Kun
Publicado: (2018)

Correlation of BDNF, VEGF, TNF‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients
por: Chukaew, Phatcharee, et al.
Publicado: (2022)

Motor, cognitive, and combined rehabilitation approaches on MS patients’ cognitive impairment
por: Argento, Ornella, et al.
Publicado: (2022)

Puerarin Alleviates Vascular Cognitive Impairment in Vascular Dementia Rats
por: Zhu, Tiantian, et al.
Publicado: (2021)

Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia
por: Vinciguerra, Luisa, et al.
Publicado: (2019)

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
por: Uemura, Maiko T., et al.
Publicado: (2020)

Regulatory microRNAs and vascular cognitive impairment and dementia
por: Zhang, Jing, et al.
Publicado: (2020)

Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia
por: Linh, Tran Thanh Duy, et al.
Publicado: (2022)

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study
por: Antczak, Jakub, et al.
Publicado: (2018)

Effects of Acupuncture on Vascular Cognitive Impairment with No Dementia: A Randomized Controlled Trial
por: Huang, Li, et al.
Publicado: (2021)

White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia
por: Liu, Qing, et al.
Publicado: (2017)

Vascular cognitive impairment and dementia: An early career researcher perspective
por: Silva, Nárlon C. Boa Sorte, et al.
Publicado: (2022)

Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults
por: Agrawal, Sonal, et al.
Publicado: (2022)

A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care
por: Xu, Zijun, et al.
Publicado: (2020)

Effects of a specially designed aerobic dance routine on mild cognitive impairment
por: Zhu, Yi, et al.
Publicado: (2018)

An open trial of individualized face-to-face cognitive behavior therapy for psychological distress in parents of children after end of treatment for childhood cancer including a cognitive behavioral conceptualization
por: Ljungman, Lisa, et al.
Publicado: (2018)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
por: Goedegebuure, Ruben S.A., et al.
Publicado: (2020)

Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
por: Kalaria, Raj N.
Publicado: (2016)

An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder
por: Desousa, Avinash
Publicado: (2010)

Lipo-prostaglandin E(1) modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway
por: Liu, Bohui, et al.
Publicado: (2017)

Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia
por: Trigiani, Lianne J., et al.
Publicado: (2019)

Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study
por: Bunch, T. Jared, et al.
Publicado: (2019)

The profile of behavioral and psychological symptoms in vascular cognitive impairment with and without dementia
por: Gupta, Meena, et al.
Publicado: (2013)

Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia
por: Price, Brittani R., et al.
Publicado: (2018)

Decreased Serum NCAM Levels Associated with Cognitive Impairment in Vascular Dementia
por: Zhao, Jun, et al.
Publicado: (2021)

MicroRNA-Based Diagnosis and Therapeutics for Vascular Cognitive Impairment and Dementia
por: Zhai, Weijie, et al.
Publicado: (2022)

Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects
por: Tian, Zhengming, et al.
Publicado: (2022)

A Novel Needle Mouse Model of Vascular Cognitive Impairment and Dementia
por: Weng, Zhongfang, et al.
Publicado: (2023)

The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods
por: Xie, Yi, et al.
Publicado: (2019)

FLUOXETINE AND VASCULAR HEADACHES
por: Andrade, Chittaranjan
Publicado: (1994)

Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia
por: Gannon, Olivia J., et al.
Publicado: (2023)

Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects
por: Moore, Kenneth Todd, et al.
Publicado: (2015)

Vascular cognitive impairment
por: Suvarna, Alladi
Publicado: (2009)

Vascular cognitive impairment
por: Yassuda, Mônica Sanches, et al.
Publicado: (2017)

Vascular Cognitive Impairment
por: Gottesman, Rebecca F., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_spp10lmu4329puumohi70fs8i2